Medicine recalls
|
| |
| The United Kingdom: Recall: Class 3 Medicines Recall: A. Menarini Farmaceutica Internazionale Srl, Invokana 300mg tablets (Northern Ireland only), EL(24)A/13 |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch of Invokana 300mg tablets (batch number: NDL0N00; 30 tablets) as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market. This affects Invokana 300mg (30 tablets) in Northern Ireland only.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-3-medicines-recall-a-menarini-farmaceutica-internazionale-srl-invokana-300mg-tablets-northern-ireland-only-el-24-a-slash-13
In Hong Kong, Invokana Tablets 300mg (HK-63500) and Invokana Tablets 300mg (HK-66455) are pharmaceutical products registered by Johnson & Johnson (Hong Kong) Ltd. The products are prescription-only medicines. As confirmed by the company, the affected batch has not been imported into Hong Kong.
Ends/ Wednesday, April 17, 2024
Issued at HKT 15:00
|
| |
